Skip to main content

Amedisys Inc. (AMED)

NASDAQ: AMED · IEX Real-Time Price · USD
171.13 2.11 (1.25%)
Sep 17, 2021 4:00 PM EDT - Market closed
Market Cap5.58B
Revenue (ttm)2.20B
Net Income (ttm)247.15M
Shares Out32.59M
EPS (ttm)7.45
PE Ratio22.98
Forward PE27.03
Dividendn/a
Ex-Dividend Daten/a
Volume680,091
Open169.88
Previous Close169.02
Day's Range169.52 - 172.69
52-Week Range166.01 - 325.12
Beta0.50
AnalystsBuy
Price Target240.92 (+40.8%)
Est. Earnings DateNov 3, 2021

About AMED

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its...

IndustryHealth Care Providers & Services
Founded1982
CEOPaul Kusserow
Employees21,000
Stock ExchangeNASDAQ
Ticker SymbolAMED
Full Company Profile

Financial Performance

In 2020, Amedisys's revenue was $2.07 billion, an increase of 5.93% compared to the previous year's $1.96 billion. Earnings were $183.61 million, an increase of 44.76%.

Financial Statements

Analyst Forecast

According to 14 analysts, the average rating for Amedisys stock is "Buy." The 12-month stock price forecast is 240.92, which is an increase of 40.78% from the latest price.

Price Target
$240.92
(40.78% upside)
Analyst Consensus: Buy

News

EHC or AMED: Which Is the Better Value Stock Right Now?

EHC vs. AMED: Which Stock Is the Better Value Option?

Other symbols:EHC
4 days ago - Zacks Investment Research

Amedisys (AMED) Down 6.5% Since Last Earnings Report: Can It Rebound?

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?

2 weeks ago - Zacks Investment Research

7 Stocks to Buy That Could Benefit From Democrats Spending Big

Investors can capitalize on Democratic spending no matter their affiliation. Here are the stocks to buy based on boosts in renewables, health care and infrastructure.

Other symbols:CATFSLRHASIMTOSCRSEDG
2 weeks ago - InvestorPlace

EHC vs. AMED: Which Stock Should Value Investors Buy Now?

EHC vs. AMED: Which Stock Is the Better Value Option?

Other symbols:EHC
3 weeks ago - Zacks Investment Research

Will Amedisys Stock Rebound After Hitting Its 52-Week Low?

The stock price of Amedisys, a home-health and hospice company, reached its 52-week low of $175 in yesterday's trading session. AMED stock has seen a gradual decline from levels of over $310 in Jan and ...

3 weeks ago - Forbes

Amedisys (AMED) Suffers From Low Occupancy Amid Pandemic

The prolonged and lingering impact of COVID-19 on Amedisys (AMED) Hospice business has hampered its ability to grow at the earlier-projected rates.

1 month ago - Zacks Investment Research

Why Amedisys Stock Is Crashing Today

The company provided disappointing full-year guidance.

1 month ago - The Motley Fool

Amedisys (AMED) Q2 Earnings Beat Estimates, Margins Grow

Amedisys (AMED) reports better-than-expected earnings for the second quarter with strong performance in Home Health and Hospice segments.

1 month ago - Zacks Investment Research

Amedisys (AMED) Beats Q2 Earnings Estimates

Amedisys (AMED) delivered earnings and revenue surprises of 3.05% and -0.09%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Amedisys Reports Second Quarter 2021 Financial Results, Closing of Contessa Acquisition, Expansion of Credit Facility...

BATON ROUGE, La., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2021.

1 month ago - GlobeNewsWire

Healthcare Stock Needs a Post-Earnings Pop

Amedisys, Inc. (NASDAQ:AMED) is one of the largest home health providers and second largest hospice care provider in the U.S. In the thick of earnings season , the company will step into the confessiona...

1 month ago - Schaeffers Research

Amedisys (AMED) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

EHC or AMED: Which Is the Better Value Stock Right Now?

EHC vs. AMED: Which Stock Is the Better Value Option?

Other symbols:EHC
1 month ago - Zacks Investment Research

Amedisys (AMED) Latest New York Assets Buyout Aids Home Health

The latest development remains in line with Amedisys' (AMED) ongoing efforts to expand footprint in key markets.

2 months ago - Zacks Investment Research

Amedisys' (AMED) VNA Assets Buyout Boosts Home Health-Hospice

Leveraging on VNA's home health and hospice care legacy, Amedisys (AMED) expects to provide additional scale and resources.

2 months ago - Zacks Investment Research

Amedisys' (AMED) Contessa Buyout to Boost Home Health Business

Amedisys (AMED) inks deal to acquire Contessa Health to boost home health and hospice services business.

2 months ago - Zacks Investment Research

Amedisys (AMED) Soars 6.7%: Is Further Upside Left in the Stock?

Amedisys (AMED) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

2 months ago - Zacks Investment Research

Amedisys Announces Agreement to Acquire Contessa Health, Creating a Comprehensive Home Healthcare Delivery Platform

Strategic acquisition will add tech-enabled, higher-acuity hospital at home and skilled-nursing facility at home services, advanced claims analytics platform, network management and additional risk-taki...

2 months ago - GlobeNewsWire

DVA or AMED: Which Is the Better Value Stock Right Now?

DVA vs. AMED: Which Stock Is the Better Value Option?

Other symbols:DVA
2 months ago - Zacks Investment Research

DVA vs. AMED: Which Stock Is the Better Value Option?

DVA vs. AMED: Which Stock Is the Better Value Option?

Other symbols:DVA
3 months ago - Zacks Investment Research

These are Wall Street's top analysts favorite stocks heading into June

TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Deere & Advanced Micro Devices.

Other symbols:AMDATRCDEZS
3 months ago - CNBC

DVA vs. AMED: Which Stock Should Value Investors Buy Now?

DVA vs. AMED: Which Stock Is the Better Value Option?

Other symbols:DVA
3 months ago - Zacks Investment Research

Here's Why You Should Buy Amedisys (AMED) Stock Now

Investors are optimistic about Amedisys (AMED) on bright Personal Care prospects, and strategic acquisitions and partnerships.

4 months ago - Zacks Investment Research

Amedisys (AMED) to Buy VNA Hospice, Home Health, Expand in NE

The acquisition is going to expand Amedisys' (AMED) presence in Omaha and Council Bluffs' healthcare communities.

4 months ago - Zacks Investment Research

Amedisys to Present at the 2021 RBC Capital Markets Global Healthcare Conference

BATON ROUGE, La., May 10, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, Chairm...

4 months ago - GlobeNewsWire